Biotechnology Instruments Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 91.11 Bn

Forecast Year, 2035

USD 133.49 Bn

CAGR, 2026 - 2035

3.89%

Report Coverage

Global

What is the Biotechnology Instruments Market Size?

The global biotechnology instruments market size is calculated at USD 91.11 billion in 2025 and is predicted to increase from USD 94.76 billion in 2026 to approximately USD 133.49 billion by 2035, expanding at a CAGR of 3.89% from 2026 to 2035.

Market Highlights

• North America led the global market with the largest market share of 40% in 2025.
• By product, the life science consumables segment has held the largest revenue share of 55% in 2025.
• By product, the medical laser segment held the largest share in the prepaid card market for 2025.
• By end user, the hospitals & healthcare facilities segment held the largest share in the prepaid card market for 2025.

How is AI contributing to the Biotechnology Instruments Industry?

The presence of Artificial intelligence in the biotechnological field is something that has improved research considerably. It did this through better handling of data, faster design of experiments, and betterment of the processes involved in decision-making. Automated systems have taken care of all the repetitive tasks in the lab and have also combined the data from different sources for quick interpretation. The AI-driven processes have also minimized human errors and enabled the researchers to go deeper into the scientific world.

Biotechnology Instruments Market Growth Factors

The increased adoption of the point of care diagnostic devices across the healthcare units is augmenting the growth of the global biotechnology instruments market. The growing needs for the development of vaccines, drugs, therapies, and diagnostic devices has fueled the demand for the biotechnology instruments across the globe. The rising investments in the research & development has improved the capabilities of the biotechnology instruments that further resulted in the enhancements of the point of care testing systems. The biotechnology instruments are extensively used in the production of various novel therapies, diagnostic devices, and gene modifications in the life science filed. The surging usage of the biotechnology instruments in the agricultural field has resulted in the development of the transgenic crops, which are resistant to pests and insects and provides higher yields. The growing concerns regarding the safety of environment from toxic and harmful chemicals is fueling the growth of the biotechnology instruments. The biotechnology instruments can help to degrade the toxicity of various harmful chemicals and thus help in resolving environmental issues. All these factors are expected to drive the growth of the global biotechnology instruments market during the forecast period.

The rising prevalence of various chronic diseases such as cancer, cardiovascular diseases, diabetes, and respiratory diseases is significantly boosting the usage of the biotechnology instruments in the production ofvarious new drugs and therapies. Furthermore, the increasing investments by the biopharmaceutical companies towards the development of vaccines, medicines, and diagnostic tests is expected to have a positive and significant impact on the growth of the global biotechnology instruments market. The rising demand for the personalized medicines pertaining to the biological make up and the rising efforts to reduce the side-effects of the medicines is fueling the consumption of the biotechnology instruments. The rapid surge in the usage of the 2D and 3D cell cultures in the drug discovery and manufacturing of compounds is further driving the growth of the biotechnology instruments market across the globe.

The outbreak of the COVID-19 had a significant impact on the biotechnology instruments market in 2020. The pandemic spiked the demand for the biotechnology instruments as the demand for the RT-PCR tests were growing at a burgeoning rate across the globe. The demand for the RT-PCR is expected to sustain during the forecast period and hence, the growth will be significantly attributed to the impact of the COVID-19 pandemic on the global biotechnology instruments market.

Market Outlook

[[market_outlook]]

Market Scope

Biotechnology Instruments Market Segmental Insights

[[segment_insights]]

Biotechnology Instruments Market Regional Insights

[[regional_insights]]

Biotechnology Instruments Market Value Chain Analysis

[[value_chain]]

Top Companies in the Biotechnology Instruments Market & Their Offerings

[[market_company]]

Other Major Companies

• AngioDynamics
• Becton, Dickinson, and Company
• BioMerieux SA
• Bio-Rad Laboratories
• BioTek Instruments, Inc.
• Candela Medical
• Cynosure, LLC
• Danaher Corporation
• Endress+Hauser
• F. Hoffmann-La Roche Ltd.
• IIlumina Inc.
• IRIDEX
• Lumenis

Segments Covered in the Report

[[segment_covered]]